SEHCF (SEHCF) Stock Price & Analysis
SEHCF (SEHCF) rose 0.00% to USD 0.5 as of June 10, 2026 at 06:56 UTC, according to Nexqual real-time market data.
SEHCF last closed at USD 0.5; the session ranged USD 0.36–0.36 on volume of 19 shares. Market capitalization is $6.44M, with a 52-week range of USD 0.36–0.64 (PNK). Source: Nexqual, June 10, 2026 at 06:56 UTC.
Key Statistics (as of June 10, 2026 at 06:56 UTC)
| Price | USD 0.5 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.5 |
| Open | USD 0.36 |
| Day Range | USD 0.36 – 0.36 |
| 52-Week Range | USD 0.36 – 0.64 |
| Volume | 19 shares |
| Market Cap | $6.44M |
| Exchange | PNK |
Technical Analysis (SEHCF)
Nexqual's technical model rates SEHCF "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 06:56 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0.5) |
| MACD | 0 (negative) |
Analyst Ratings (SEHCF)
Wall Street analysts rate SEHCF "None", per Nexqual as of June 10, 2026 at 06:56 UTC.
| Consensus Rating | None |
|---|
Earnings (SEHCF)
Source: Nexqual, June 10, 2026 at 06:56 UTC.
Financials & Fundamentals (SEHCF)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -360.68% |
| Current Ratio | 0.02 |
| Total Cash | $3,935 |
| Total Debt | $139,478 |
| Free Cash Flow | $-1.90M |
Source: Nexqual, June 10, 2026 at 06:56 UTC.
Financial Health Score (SEHCF)
Nexqual rates SEHCF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 06:56 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $4K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$818K |
| Efficiency | Critical — ROE -361%, ROA -142.1% |
Ownership (SEHCF)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 12.92M |
| Float | 12.91M |
Source: Nexqual, June 10, 2026 at 06:56 UTC.
Leadership (SEHCF)
SEHCF is led by Robert Dubeau, President, CEO & Director, per Nexqual as of June 10, 2026 at 06:56 UTC.
| President, CEO & Director | Robert Dubeau |
|---|---|
| CFO, Corporate Secretary & Director | Christopher Robert Cooper BBA (age 55) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NLVVF | New Leaf Ventures Inc. | USD 0 | ▲ 0% |
| CBDHF | HEMPFUSION WELLNESS INC | USD 0 | ▲ 0% |
| ISCNF | ISRACANN BIOSCIENCES INC | USD 0 | ▲ 0% |
| CLABF | Core One Labs Inc. | USD 0 | ▲ 0% |
| JUVAF | Juva Life Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 06:56 UTC. This page is informational and not investment advice.